Previous 10 |
VectivBio Holding ([[VECT]] +1.9%) has dosed the first patient in its Phase 2 STARS Nutrition metabolic balance study evaluating apraglutide in colon-in-continuity ((CIC)) patients with short bowel syndrome with intestinal failure (SBS-IF). This Phase 2 trial is designed to evaluate the effic...
Phase 2 trial will evaluate the efficacy of once-weekly apraglutide in increasing intestinal energy absorption in CIC patients with SBS-IF CIC patients represent over half of the total SBS-IF population Initial readout of 4-week intestinal energy absorption data expected in 1H...
VectivBio (VECT) has named Omar Khwaja as its new chief medical officer.In addition, Christian Meyer was appointed to the new position of chief operating officer.Khwaja was previously CMO at Voyager Therapeutics, while Meyer, a founding member of the company, was previously CMO at Therachon A...
VectivBio Holding (VECT) announces the appointment of Omar Khwaja as the company's chief medical officer.The move means that Christian Meyer will move to the newly created position of chief operating officer, the company said.Khwaja has over two decades of experience, and ...
Christian Meyer, currently Chief Development Officer, to assume the newly created position of Chief Operating Officer Senior leadership appointments strengthen VectivBio as it continues development of apraglutide in short bowel syndrome and graft versus host disease, and expansion...
Growth beyond COVID for Quest DiagnosticsQuest Diagnostics (DGX) is poised for top-line growth even as COVID-19 testing wanes, according to UBS, which has upgraded shares from neutral to buy.Analyst Kevin Caliendo has also upped his price target to $158 from $135, implying upside of 19% from ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead A barrage of earnings reports will arrive next week. The Q1 earnings season so far has seen a record 87% of S&P 500 ...
News, Short Squeeze, Breakout and More Instantly...
NAARDEN, The Netherlands and MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of card...
Simplicity Esports (WINR) is expected to report for quarter end 2024-02-29 BankUnited Inc. (BKU) is expected to report $0.62 for Q1 2024 Winmark Corporation (WINA) is expected to report for Q1 2024 SL Green Realty Corp (SLG) is expected to report $2.17 for Q1 2024 Union Bankshares...
VectivBio Holding AG (VECT) is expected to report for quarter end 2023-12-31